Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 416 articles:
HTML format



Single Articles


    August 2021
  1. AGAWA K, Yamashita K, Nakagawa A, Yamada K, et al
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4117-4126.
    PubMed     Abstract available


  2. TOKASHIKI K, Okamoto I, Okada T, Sato H, et al
    Postoperative Complications of Jejunal and Skin Valve Reconstruction in Free Reconstructive Surgery for Hypopharyngeal Carcinoma.
    Anticancer Res. 2021;41:4033-4038.
    PubMed     Abstract available


  3. LANDSTROM F, Kristiansson S, Reizenstein J
    The Role of Electrochemotherapy in Curative Treatment of Head and Neck Cancer and Advanced Skin Cancer: A Need for New Treatment Protocols?
    Anticancer Res. 2021;41:3977-3982.
    PubMed     Abstract available


  4. YAMASHITA K, Miyazaki Y, Nakatani D, Masuike Y, et al
    OSK-0028 in Patients With Esophageal Cancer Undergoing Esophagectomy: A Double-blind, Randomised Controlled Trial.
    Anticancer Res. 2021;41:3875-3884.
    PubMed     Abstract available


  5. DE OLIVEIRA NETO CP, Brito HO, DA Costa RMG, Brito LMO, et al
    Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis.
    Anticancer Res. 2021;41:3707-3716.
    PubMed     Abstract available


    July 2021
  6. CAO C, Poti SM, Ledgerwood LG, Lai J, et al
    Mixed HPV-related Neuroendocrine Carcinoma and HPV-related Squamous Cell Carcinoma of the Base of Tongue in a Patient With Incidental Identification of Synchronous Metastatic Papillary Thyroid Carcinoma.
    Anticancer Res. 2021;41:3639-3642.
    PubMed     Abstract available


  7. LANDSTROM F, Kristiansson S, Appelros P
    Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area.
    Anticancer Res. 2021;41:3519-3522.
    PubMed     Abstract available


  8. KNITTER S, Andreou A, Hofmann T, Chopra S, et al
    Minimally Invasive Versus Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching Analysis.
    Anticancer Res. 2021;41:3499-3510.
    PubMed     Abstract available


  9. LUNDIN E, Reizenstein J, Landstrom F, Bergqvist M, et al
    Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell Cancer.
    Anticancer Res. 2021;41:3489-3498.
    PubMed     Abstract available


  10. FUJITA J, Nakajima M, Muroi H, Kikuchi M, et al
    The Prognostic Significance of Plakophilin-1 Expression in Esophageal Cancer.
    Anticancer Res. 2021;41:3401-3407.
    PubMed     Abstract available


  11. KII T, Sakuma K, Tanaka A
    PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:3363-3370.
    PubMed     Abstract available


  12. HYAKUSOKU H, Sawakuma K, Sano D, Takahashi H, et al
    FosL1 Regulates Regional Metastasis of Head and Neck Squamous Cell Carcinoma by Promoting Cell Migration, Invasion, and Proliferation.
    Anticancer Res. 2021;41:3317-3326.
    PubMed     Abstract available


    June 2021
  13. STAACKMANN C, Ribbat-Idel J, Perner S, Idel C, et al
    Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival.
    Anticancer Res. 2021;41:3205-3210.
    PubMed     Abstract available


  14. HAMAI Y, Emi M, Ibuki Y, Kurokawa T, et al
    Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy.
    Anticancer Res. 2021;41:3011-3021.
    PubMed     Abstract available


  15. KYRODIMOS E, Chrysovergis A, Mastronikolis N, Tsiambas E, et al
    Impact of Topoisomerases Complex Deregulation on Head and Neck Carcinoma Genomic Instability.
    Anticancer Res. 2021;41:2773-2779.
    PubMed     Abstract available


  16. RADES D, Staackmann C, Ribbat-Idel J, Perner S, et al
    A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck.
    Anticancer Res. 2021;41:3055-3058.
    PubMed     Abstract available


  17. SARMA D, Karna R, Nasrullah A, Zhang Q, et al
    Primary Esophageal Small Cell Carcinoma Masquerading as Non-Hodgkin Lymphoma in a Young Patient.
    Anticancer Res. 2021;41:3023-3027.
    PubMed     Abstract available


  18. OKUHATA K, Monzen H, Tamura M, Matsumoto K, et al
    Plan Complexity and Delivery Accuracy of Knowledge-based Volumetric Modulated Arc Therapy Plans with Single Optimization for Oropharyngeal Cancer.
    Anticancer Res. 2021;41:2925-2931.
    PubMed     Abstract available


    May 2021
  19. RADES D, Staackmann C, Schild SE
    Karnofsky Performance Score - An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer.
    Anticancer Res. 2021;41:2495-2499.
    PubMed     Abstract available


  20. HAAG A, Huffman D, Peterson C, Shankar K, et al
    Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma.
    Anticancer Res. 2021;41:2485-2488.
    PubMed     Abstract available


  21. IWASAKI T, Onda T, Honda H, Hayashi K, et al
    Over-expression of PDE5 in Oral Squamous Cell Carcinoma - Effect of Sildenafil Citrate.
    Anticancer Res. 2021;41:2297-2306.
    PubMed     Abstract available


    April 2021
  22. YU WN, Lin HF, Lee YI, Shia WC, et al
    PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
    Anticancer Res. 2021;41:2177-2182.
    PubMed     Abstract available


  23. SAKAI M, Sohda M, Saito H, Nakazawa N, et al
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting.
    Anticancer Res. 2021;41:2141-2145.
    PubMed     Abstract available


  24. FRIEDRICH RE, Scheuer HT, Zustin J, Luebke AM, et al
    Microdont Developing Outside the Alveolar Process and Within Oral Diffuse and Plexiform Neurofibroma in Neurofibromatosis Type 1.
    Anticancer Res. 2021;41:2083-2092.
    PubMed     Abstract available


  25. SUZUKI M, Takenaka Y, Kishikawa T, Yamamoto Y, et al
    Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer.
    Anticancer Res. 2021;41:2045-2051.
    PubMed     Abstract available


  26. TAKAKUSAGI Y, Kusunoki T, Kano K, Anno W, et al
    Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer.
    Anticancer Res. 2021;41:1951-1958.
    PubMed     Abstract available


  27. FUKUDA M, Ogasawara Y, Hayashi H, Okuyama A, et al
    Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling.
    Anticancer Res. 2021;41:1785-1792.
    PubMed     Abstract available


  28. PAWLICZAK J, Kolb M, Bauer M, Gminski R, et al
    Micronucleus Formation in Primary Oropharyngeal Epithelial Cells Reveals Mutagenicity of Cement Dusts.
    Anticancer Res. 2021;41:1849-1858.
    PubMed     Abstract available


  29. HOTTA H, Hamamura K, Shibuya H, Ohmi Y, et al
    Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling.
    Anticancer Res. 2021;41:1821-1830.
    PubMed     Abstract available


  30. OGO A, Miyake S, Kubota H, Higashida M, et al
    The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
    Anticancer Res. 2021;41:1771-1778.
    PubMed     Abstract available


  31. KOERDT S, Raguse JD, Neumann F, Beck-Broichsitter B, et al
    Value of Panendoscopy in the Identification of Synchronous Malignancies in Patients Suffering from Oral Squamous Cell Carcinoma Without Clinical Signs of a Second Primary Tumor.
    Anticancer Res. 2021;41:2039-2044.
    PubMed     Abstract available


    March 2021
  32. MARCHAND-CRETY C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, et al
    Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
    Anticancer Res. 2021;41:1555-1561.
    PubMed     Abstract available


  33. FUKUDA N, Toda K, Ohmoto A, Wang X, et al
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Anticancer Res. 2021;41:1683-1691.
    PubMed     Abstract available


  34. OWIN N, Elsayad K, Rolf D, Haverkamp U, et al
    Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies.
    Anticancer Res. 2021;41:1587-1592.
    PubMed     Abstract available


  35. KURIYAMA K, Sohda M, Watanabe T, Saito H, et al
    Resistance to Preoperative Oral Care Is Associated With Postoperative Pneumonia After Oesophageal Cancer Surgery.
    Anticancer Res. 2021;41:1507-1514.
    PubMed     Abstract available


  36. FRANZEN AM, Windfuhr JP
    Tonsillectomy as a Prevention Strategy in the Light of Increasing Incidence of Oropharyngeal Cancer - a Research of Current Literature.
    Anticancer Res. 2021;41:1157-1161.
    PubMed     Abstract available


    February 2021
  37. MENG X, Matsumoto F, Mori T, Miura N, et al
    BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:1089-1099.
    PubMed     Abstract available


  38. MEIROVITZ A, Gross M, Leibovici V, Sheva K, et al
    Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients.
    Anticancer Res. 2021;41:1083-1087.
    PubMed     Abstract available


  39. NISHII N, Hirotsu Y, Koida N, Takahashi Y, et al
    Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
    Anticancer Res. 2021;41:1035-1040.
    PubMed     Abstract available


  40. TADA H, Takahashi H, Ida S, Mito I, et al
    The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:885-893.
    PubMed     Abstract available


  41. RADES D, Narvaez CA, Janssen S, SchrOder U, et al
    Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer.
    Anticancer Res. 2021;41:877-884.
    PubMed     Abstract available


  42. LEE HP, Tsai KW, Lee CC
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
    Anticancer Res. 2021;41:803-810.
    PubMed     Abstract available


  43. INOUE M, Takeuchi H, Matsuda S, Nishi T, et al
    IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
    Anticancer Res. 2021;41:783-794.
    PubMed     Abstract available


  44. UEDA S, Goto M, Hashimoto K, Imazawa M, et al
    Salivary CPLANE1 Levels as a Biomarker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:765-772.
    PubMed     Abstract available


  45. JIANG C, Lee SH, Park JH, Lee JS, et al
    A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
    Anticancer Res. 2021;41:687-697.
    PubMed     Abstract available


    January 2021
  46. NARVAEZ CA, Schild SE, Janssen S, Schroeder U, et al
    Accelerated Fractionation With Concomitant Boost vs. Conventional Radio-chemotherapy for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head-and-Neck (SCCHN).
    Anticancer Res. 2021;41:477-484.
    PubMed     Abstract available


  47. SOHDA M, Miyazaki T, Watanabe T, Nakazawa N, et al
    Utility of Thermography of Reconstructed Gastric Conduit for Predicting Postoperative Anastomotic Leakage After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2021;41:453-458.
    PubMed     Abstract available


  48. SASAKI K, Osako Y, Urata M, Noda M, et al
    Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy.
    Anticancer Res. 2021;41:385-389.
    PubMed     Abstract available


  49. ZHANG H, Yi J, Kim E, Choo Y, et al
    20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway.
    Anticancer Res. 2021;41:227-235.
    PubMed     Abstract available


  50. WILHELM C, Hackenberg S, Bregenzer M, Meyer T, et al
    Effect of Hypoxia on Proliferation and the Expression of the Genes HIF-1alpha and JMJD1A in Head and Neck Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2021;41:113-122.
    PubMed     Abstract available


  51. KOUKOURAKIS IM, Zygogianni A, Kouloulias V, Kyrgias G, et al
    Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?
    Anticancer Res. 2021;41:467-475.
    PubMed     Abstract available


  52. STARK CR, Gustavsson I, Horal P, Kotopouli M, et al
    Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis.
    Anticancer Res. 2021;41:269-277.
    PubMed     Abstract available


  53. LAI KC, Chia YT, Yih LH, Lu YL, et al
    Antitumor Effects of the Novel Quinazolinone Holu-12: Induction of Mitotic Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma CAL27 Cells.
    Anticancer Res. 2021;41:259-268.
    PubMed     Abstract available


  54. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Spyropoulou D, et al
    Comparative E-Cadherin Digital Expression Analysis in HPV and non-HPV Related Squamous Cell Carcinoma of the Oral Cavity.
    Anticancer Res. 2021;41:163-167.
    PubMed     Abstract available


  55. FURUKAWA K, Kawasaki G, Yoshida T, Umeda M, et al
    Clinicopathological and Prognostic Analysis of PD-L1 and PD-L2 Expression in Surgically Resected Primary Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:101-111.
    PubMed     Abstract available


  56. UCHI R, Jiromaru R, Yasumatsu R, Yamamoto H, et al
    Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma.
    Anticancer Res. 2021;41:71-79.
    PubMed     Abstract available


    December 2020
  57. SUGIURA K, Nakajima S, Kato I, Okubo-Sato M, et al
    Hypoxia and CD11b+ Cell Influx Are Strongly Associated With Lymph Node Metastasis of Oral Cancer.
    Anticancer Res. 2020;40:6845-6852.
    PubMed     Abstract available


  58. LIU B, Shiraga S, Mortenson MM, Lai J, et al
    Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:7053-7056.
    PubMed     Abstract available


  59. NECKEL N, Michael M, Troeltzsch D, WUster J, et al
    Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6987-6995.
    PubMed     Abstract available


  60. CHEN CH, Huang YC, Lee YH, Tan ZL, et al
    Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
    Anticancer Res. 2020;40:6723-6732.
    PubMed     Abstract available


    November 2020
  61. KIM SH, Cho YK, Huh JH, Kang JG, et al
    Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.
    Anticancer Res. 2020;40:6137-6150.
    PubMed     Abstract available


  62. TRUMBULL D, Lemini R, Attwood K, Kukar M, et al
    Gastric Cancer Disparities Among Asian American Subpopulations.
    Anticancer Res. 2020;40:6381-6385.
    PubMed     Abstract available


  63. DE JESUS OLIVEIRA KATO V, DE Abreu MC, DE Brito Kato AM, DE Souza LL, et al
    Significance of P16(INK4A) Expression and PTEN Loss of Heterozygosity in Human Papilloma Virus-related Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6355-6366.
    PubMed     Abstract available


  64. SUNG ES, Kim JY, Ahn YT, Lee IW, et al
    Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
    Anticancer Res. 2020;40:6295-6303.
    PubMed     Abstract available


  65. BIRK R, Schell A, Aderhold C, Hoch S, et al
    Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC.
    Anticancer Res. 2020;40:6195-6203.
    PubMed     Abstract available


  66. MARUYAMA N, Umikawa M, Matsumoto H, Maruyama T, et al
    miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).
    Anticancer Res. 2020;40:6101-6113.
    PubMed     Abstract available


  67. PELTONEN J, Tuomainen K, Sallinen T, Faress I, et al
    Effect of Sex Steroid Hormones on Tongue Cancer Cells In Vitro.
    Anticancer Res. 2020;40:6029-6037.
    PubMed     Abstract available


    October 2020
  68. KAWAKITA Y, Motoyama S, Sato Y, Wakita A, et al
    Prognostic Significance of Combined Platelet Distribution Width and C-Reactive Protein Score in Esophageal Cancer.
    Anticancer Res. 2020;40:5715-5725.
    PubMed     Abstract available


  69. SHIH LC, Tsai CW, Chang WS, Shen TC, et al
    Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan.
    Anticancer Res. 2020;40:5503-5508.
    PubMed     Abstract available


  70. KOENIGSBERG C, Ondrey FG
    Genomic Database Analysis for Head and Neck Cancer Prevention Targets: MTOR Signal Transduction Pathway.
    Anticancer Res. 2020;40:5417-5421.
    PubMed     Abstract available


  71. TAKAGI K, Buettner S, Ijzermans JNM, Wijnhoven BPL, et al
    Systematic Review on the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2020;40:5343-5349.
    PubMed     Abstract available


  72. HAAG A, Jayakrishnan T, Shah D, Sandhu A, et al
    First Reported Case of Localized Extra-pulmonary Small Cell Carcinoma (EPSC) of the Esophagus Treated With Triple Therapy.
    Anticancer Res. 2020;40:5919-5923.
    PubMed     Abstract available


  73. TANISHIMA Y, Nishikawa K, Arakawa Y, Matsumoto A, et al
    Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer.
    Anticancer Res. 2020;40:5829-5835.
    PubMed     Abstract available


  74. KUVENDJISKA J, Pitman MB, Martini V, Braun C, et al
    Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Anticancer Res. 2020;40:5679-5685.
    PubMed     Abstract available


  75. HUBER L, Birk R, Knuettel M, Rotter N, et al
    FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.
    Anticancer Res. 2020;40:5621-5630.
    PubMed     Abstract available


    September 2020
  76. FUSHIMI C, Okamoto I, Matsuki T, Masubuchi T, et al
    Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma.
    Anticancer Res. 2020;40:5277-5283.
    PubMed     Abstract available


  77. KUBOTA H, Hirai T, Yamauchi A, Ogo A, et al
    Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
    Anticancer Res. 2020;40:5043-5048.
    PubMed     Abstract available


  78. TERATANI M, Nakamura S, Sakagami H, Fujise M, et al
    Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.
    Anticancer Res. 2020;40:4885-4894.
    PubMed     Abstract available


    August 2020
  79. KUROKAWA T, Hamai Y, Emi M, Ibuki Y, et al
    Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy.
    Anticancer Res. 2020;40:4387-4394.
    PubMed     Abstract available


  80. LEE MY, Fowler N, Adelstein D, Koyfman S, et al
    Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin.
    Anticancer Res. 2020;40:4207-4214.
    PubMed     Abstract available


  81. TSUCHIHASHI K, Nakatsugawa M, Kobayashi JI, Sasaya T, et al
    Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4319-4326.
    PubMed     Abstract available


    July 2020
  82. KUBO K, Murakami Y, Imano N, Takeuchi Y, et al
    A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers.
    Anticancer Res. 2020;40:4183-4190.
    PubMed     Abstract available


  83. JEONG JY, Park TI, Ahn D
    Comprehensive Analysis and Clinical Implication of PD-L1 Expression Considering HPV Status in Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4001-4010.
    PubMed     Abstract available


  84. KOMATSU N, Komatsu M, Ohashi R, Horii A, et al
    Photosensitizer With Illumination Enhances In Vivo Antitumor Effect of Anti-ROBO1 Immunotoxin on Maxillary Sinus Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3793-3799.
    PubMed     Abstract available


  85. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Tsiambas E, et al
    Chromosome 17 In Situ Hybridization Grid-based Analysis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3759-3764.
    PubMed     Abstract available


  86. LI CH, Shih LC, Hsu CL, Lee HT, et al
    The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.
    Anticancer Res. 2020;40:3707-3712.
    PubMed     Abstract available


  87. IIJIMA Y, Bandow K, Amano S, Sano M, et al
    Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
    Anticancer Res. 2020;40:3685-3696.
    PubMed     Abstract available


  88. KRAMER B, Schell A, Aderhold C, Huber L, et al
    Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3847-3855.
    PubMed     Abstract available


  89. CHO JM, Lee HJ, Chung JH, Kim WY, et al
    Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Anticancer Res. 2020;40:3801-3809.
    PubMed     Abstract available


    June 2020
  90. TADA H, Takahashi H, Ida S, Nagata Y, et al
    Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3559-3564.
    PubMed     Abstract available


  91. HIRAKAWA H, Ikegami T, Azechi S, Agena S, et al
    Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms.
    Anticancer Res. 2020;40:3277-3285.
    PubMed     Abstract available


  92. ROSAS R, Buryska S, Silver R, Wuertz B, et al
    Retinoids Augment Thiazolidinedione PPARgamma Activation in Oral Cancer Cells.
    Anticancer Res. 2020;40:3071-3080.
    PubMed     Abstract available


  93. SAMHOURI L, Kriz J, Elsayad K, Channaoui M, et al
    The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
    Anticancer Res. 2020;40:3379-3386.
    PubMed     Abstract available


  94. TUNG KL, Wu YT, Liu C, Lin SC, et al
    EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro.
    Anticancer Res. 2020;40:3255-3264.
    PubMed     Abstract available


    May 2020
  95. KIDOGAMI S, Iguchi T, Sato K, Yoshikawa Y, et al
    SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2941-2946.
    PubMed     Abstract available


  96. TAKAHASHI K, Osaka Y, Ota Y, Watanabe T, et al
    Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer.
    Anticancer Res. 2020;40:2827-2832.
    PubMed     Abstract available


  97. UTISPAN K, Koontongkaew S
    High Nitric Oxide Adaptation in Isogenic Primary and Metastatic Head and Neck Cancer Cells.
    Anticancer Res. 2020;40:2657-2665.
    PubMed     Abstract available


  98. KANGBOONRUANG K, Wongtrakoongate P, Lertsuwan K, Khachonkham S, et al
    MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin.
    Anticancer Res. 2020;40:2645-2655.
    PubMed     Abstract available


  99. PARK JJ, Hah YS, Ryu S, Cheon SY, et al
    Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Via Epithelial-to-Mesenchymal Transition.
    Anticancer Res. 2020;40:2627-2635.
    PubMed     Abstract available


  100. AHN SH, Song S, Kim S
    Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model.
    Anticancer Res. 2020;40:2707-2713.
    PubMed     Abstract available


  101. OAK ASW, Bocheva G, Kim TK, Brozyna AA, et al
    Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/beta-Catenin Pathways.
    Anticancer Res. 2020;40:2467-2474.
    PubMed     Abstract available


    April 2020
  102. KOMORI MF, Kimura T, Kariya S, Onoda T, et al
    Epidemiological Correlations Between Head and Neck Cancer and Hepatitis B Core Antibody Positivity.
    Anticancer Res. 2020;40:2393-2403.
    PubMed     Abstract available


  103. LIN CY, Fang HY, Lein MY, Lin CC, et al
    Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
    Anticancer Res. 2020;40:2387-2392.
    PubMed     Abstract available


  104. TAMAGAWA H, Aoyama T, Tamagawa A, Komori K, et al
    Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Anticancer Res. 2020;40:2365-2371.
    PubMed     Abstract available


  105. AOYAMA T, Atsumi Y, Hara K, Kazama K, et al
    Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment.
    Anticancer Res. 2020;40:2359-2364.
    PubMed     Abstract available


  106. EGGERSMANN TK, Baumeister P, Kumbrink J, Mayr D, et al
    Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Anticancer Res. 2020;40:2117-2123.
    PubMed     Abstract available


  107. TOYA R, Saito T, Matsuyama T, Kai Y, et al
    Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2073-2077.
    PubMed     Abstract available


  108. YAMAMOTO T, Niibe Y, Matsumoto Y, Dekura Y, et al
    Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.
    Anticancer Res. 2020;40:2065-2072.
    PubMed     Abstract available


  109. TAKAHASHI M, Fukuda K, Saikawa Y, Nakamura R, et al
    Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:1921-1930.
    PubMed     Abstract available


  110. INSODAITE R, Liutkevicius V, Uloza V, Solovejute R, et al
    Association Between MMP8 Gene Polymorphisms and Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2003-2009.
    PubMed     Abstract available


  111. SHIMODA Y, Yamada T, Komori K, Watanabe H, et al
    Effect of Muscle Mass Loss After Esophagectomy on Prognosis of Oesophageal Cancer.
    Anticancer Res. 2020;40:2275-2281.
    PubMed     Abstract available


    March 2020
  112. KOH HK, Park Y, Koo T, Park HJ, et al
    Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:1771-1778.
    PubMed     Abstract available


  113. DAVAKIS S, Syllaios A, Sdralis E, Lorenzi B, et al
    Hybrid Minimally-invasive Esophagectomy for Esophageal Cancer: Clinical and Oncological Outcomes.
    Anticancer Res. 2020;40:1753-1758.
    PubMed     Abstract available


  114. NGUYEN T, Bartscht T, Schild SE, Rades D, et al
    A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation.
    Anticancer Res. 2020;40:1661-1664.
    PubMed     Abstract available


  115. IGUCHI K, Kunisaki C, Sato S, Tanaka Y, et al
    Efficacy of Video-assisted Thoracoscopic Esophagectomy for Stage II/III Esophageal Cancer: Analysis Using the Propensity Scoring System.
    Anticancer Res. 2020;40:1587-1595.
    PubMed     Abstract available


  116. SIMON F, Schwenk-Zieger S, Becker S, Unger K, et al
    Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells - Role of ABCG2.
    Anticancer Res. 2020;40:1277-1284.
    PubMed     Abstract available


  117. KIM HJ, Lee HJ, Jung JH, Kim WW, et al
    Ultrasound Assessment of Synchronous Thyroid Nodules in Patients With Papillary Thyroid Cancer: A Nodule-by-nodule Analysis Between Ultrasound and Pathology.
    Anticancer Res. 2020;40:1779-1786.
    PubMed     Abstract available


  118. VITOLO V, Barcellini A, Mirandola A, Facoetti A, et al
    Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?
    Anticancer Res. 2020;40:1645-1649.
    PubMed     Abstract available


  119. SAITO M, Fujita Y, Kuribayashi N, Uchida D, et al
    Troglitazone, a Selective Ligand for PPARgamma, Induces Cell-cycle Arrest in Human Oral SCC Cells.
    Anticancer Res. 2020;40:1247-1254.
    PubMed     Abstract available


    February 2020
  120. HUANG CH, Lue KH, Hsieh TC, Liu SH, et al
    Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.
    Anticancer Res. 2020;40:1175-1181.
    PubMed     Abstract available


  121. SIERON HL, Eberle F, Gress TM, Mahnken AH, et al
    Safety of Prophylactic Gastrostomy Tube Placement and Gastrostomy Tube Usage in Patients Treated by Radio(chemo)therapy for Head and Neck Cancer.
    Anticancer Res. 2020;40:1167-1173.
    PubMed     Abstract available


  122. OHSAWA M, Hamai Y, Emi M, Takaoki F, et al
    Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery.
    Anticancer Res. 2020;40:1153-1160.
    PubMed     Abstract available


  123. SUZUKI H, Nishikawa D, Beppu S, Terada H, et al
    Prognostic Value of Age and Distant Metastasis in Differentiated Thyroid Carcinoma Undergoing Salvage Surgery.
    Anticancer Res. 2020;40:1127-1133.
    PubMed     Abstract available


  124. AOYAMA T, Hara K, Kazama K, Atsumi Y, et al
    The Short- and Long-term Outcomes of Esophagectomy for Esophageal Cancer in Patients Older than 75 Years.
    Anticancer Res. 2020;40:1087-1093.
    PubMed     Abstract available


  125. YOU JS, Lim H, Kim TH, Oh JS, et al
    25-Hydroxycholesterol Induces Death Receptor-mediated Extrinsic and Mitochondria-dependent Intrinsic Apoptosis in Head and Neck Squamous Cell Carcinoma Cells.
    Anticancer Res. 2020;40:779-788.
    PubMed     Abstract available


  126. WAER CN, Kaur P, Tumur Z, Hui DD, et al
    Rosmarinic Acid/ Blue Light Combination Treatment Inhibits Head and Neck Squamous Cell Carcinoma In Vitro.
    Anticancer Res. 2020;40:751-758.
    PubMed     Abstract available


  127. PSOMA E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, et al
    Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.
    Anticancer Res. 2020;40:677-688.
    PubMed     Abstract available


  128. SATOMI-TSUSHITA N, Honma Y, Nagashima K, Ito Y, et al
    Risk Factors of Severe Benign Cicatricial Stricture After Definitive Chemoradiation for Localized T3 Esophageal Carcinoma.
    Anticancer Res. 2020;40:1071-1077.
    PubMed     Abstract available


  129. BAUMGARTNER R, Taghizadeh H, Jomrich G, Schoppmann SF, et al
    Utilization and Efficacy of Palliative Chemotherapy for Locally Advanced or Metastatic Gastroesophageal Carcinoma.
    Anticancer Res. 2020;40:965-975.
    PubMed     Abstract available


  130. MIYAMOTO K, Minegaki T, Hirano S, Hayashi I, et al
    Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells.
    Anticancer Res. 2020;40:813-823.
    PubMed     Abstract available


  131. PAPANIKOLAOU V, Chrysovergis A, Mastronikolis N, Tsiambas E, et al
    Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:807-811.
    PubMed     Abstract available


    January 2020
  132. AOYAMA T, Kazama K, Atsumi Y, Tamagawa H, et al
    Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence.
    Anticancer Res. 2020;40:443-449.
    PubMed     Abstract available


  133. OLEJAR T, Vetvicka D, Boucek J, Zabrodsky M, et al
    The FSHR Expression in Head and Neck Squamous Cell Cancer. A Pilot Immunohistochemical Study.
    Anticancer Res. 2020;40:349-356.
    PubMed     Abstract available


  134. ROMEO V, Cuocolo R, Ricciardi C, Ugga L, et al
    Prediction of Tumor Grade and Nodal Status in Oropharyngeal and Oral Cavity Squamous-cell Carcinoma Using a Radiomic Approach.
    Anticancer Res. 2020;40:271-280.
    PubMed     Abstract available


  135. EUN YG, Yoon YJ, Won KY, Lee YC, et al
    Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model.
    Anticancer Res. 2020;40:191-199.
    PubMed     Abstract available


  136. LI J, Vangundy Z, Poi M
    Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines.
    Anticancer Res. 2020;40:67-73.
    PubMed     Abstract available


    December 2019
  137. GREHN M, Stille M, Ziemann C, Cremers F, et al
    A New Phantom for Individual Verification of the Dose Distribution in Precision Radiotherapy for Head-and-Neck Cancer.
    Anticancer Res. 2019;39:6931-6938.
    PubMed     Abstract available


  138. SANO D, Fujisawa T, Tokuhisa M, Shimizu M, et al
    Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.
    Anticancer Res. 2019;39:6819-6827.
    PubMed     Abstract available


  139. MORIMOTO M, Bijl HP, VAN DER Schaaf A, Xu CJ, et al
    Development of Normal Tissue Complication Probability Model for Trismus in Head and Neck Cancer Patients Treated With Radiotherapy: The Role of Dosimetric and Clinical Factors.
    Anticancer Res. 2019;39:6787-6798.
    PubMed     Abstract available


  140. LI CH, Sun KT, Li X, Shih LC, et al
    The Joint Effect of Interleukin-12B rs3212227 Genotype and Behavioral Factors on Oral Cancer Risk in Taiwanese.
    Anticancer Res. 2019;39:6515-6521.
    PubMed     Abstract available


  141. IIJIMA Y, Bandow K, Sano M, Hino S, et al
    In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs.
    Anticancer Res. 2019;39:6673-6684.
    PubMed     Abstract available


  142. UESAWA Y, Nagai J, Shi H, Sakagami H, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Styrylchromones.
    Anticancer Res. 2019;39:6489-6498.
    PubMed     Abstract available


  143. NAGAI J, Shi H, Sezaki N, Yoshida N, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
    Anticancer Res. 2019;39:6479-6488.
    PubMed     Abstract available


  144. NAKAMURA J, Furuya S, Hagio K, Maruyama S, et al
    Differential miRNA Expression in Basaloid Squamous Cell Carcinoma of the Oesophagus: miR-3687 Targets PGRMC2.
    Anticancer Res. 2019;39:6471-6478.
    PubMed     Abstract available


  145. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Abstract available


    November 2019
  146. HO ML, Kuo WK, Chu LJ, Yeh IH, et al
    N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
    Anticancer Res. 2019;39:6317-6324.
    PubMed     Abstract available


  147. CHO YA, Kim EK, Cho BC, Koh YW, et al
    Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node Metastasis.
    Anticancer Res. 2019;39:6307-6316.
    PubMed     Abstract available


  148. JALY AA, Thway K, Touska P, Wale A, et al
    Imaging Soft-tissue Sarcomas of the Head and Neck: A Tertiary Soft-tissue Sarcoma Unit Experience.
    Anticancer Res. 2019;39:6223-6230.
    PubMed     Abstract available


  149. MORO Y, Kogashiwa Y, Sakurai H, Takahashi R, et al
    In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells.
    Anticancer Res. 2019;39:6041-6047.
    PubMed     Abstract available


  150. UNO Y, Kanda M, Sato Y, Shimizu D, et al
    Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:6015-6023.
    PubMed     Abstract available


  151. BABA H, Kanda M, Sawaki K, Shimizu D, et al
    PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:5943-5951.
    PubMed     Abstract available


  152. MURATA T, Shimizu K, Kurohara K, Tomeoku A, et al
    Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.
    Anticancer Res. 2019;39:6057-6062.
    PubMed     Abstract available


  153. EIN L, Mei C, Bracho O, Bas E, et al
    Modulation of BDNF-TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion In Vitro.
    Anticancer Res. 2019;39:5933-5942.
    PubMed     Abstract available


    October 2019
  154. GUO JC, Lin CC, Lin CY, Hsieh MS, et al
    Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Anticancer Res. 2019;39:5675-5682.
    PubMed     Abstract available


  155. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Diameter of External Carotid Arteries in Patients With Mandibular Osteoradionecrosis.
    Anticancer Res. 2019;39:5689-5693.
    PubMed     Abstract available


  156. SEKIMIZU M, Ozawa H, Saito S, Ikari Y, et al
    Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
    Anticancer Res. 2019;39:5623-5630.
    PubMed     Abstract available


    September 2019
  157. KALFERT D, Ludvik J, Kucera R, Topolcan O, et al
    Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2019;39:5171-5177.
    PubMed     Abstract available


  158. PARK SR, Yoon DH, Kim JH, Kim YH, et al
    A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO).
    Anticancer Res. 2019;39:5123-5133.
    PubMed     Abstract available


  159. LOGANADANE G, Kann BH, Park HS, Johnson SB, et al
    Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.
    Anticancer Res. 2019;39:4885-4890.
    PubMed     Abstract available


  160. FRANZEN A, Gunzel T, Buchali A, Coordes A, et al
    Cystic Lateral Neck Lesions: Etiologic and Differential Diagnostic Significance in a Series of 133 Patients.
    Anticancer Res. 2019;39:5047-5052.
    PubMed     Abstract available


  161. OGINO I, Watanabe S, Misumi T, Hata M, et al
    Lymph Node Metastases Diagnosed by (18)F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy.
    Anticancer Res. 2019;39:4977-4985.
    PubMed     Abstract available


    August 2019
  162. FUKUOKA E, Yamashita K, Tanaka T, Sawada R, et al
    Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8(+) Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4539-4548.
    PubMed     Abstract available


  163. TANAKA Y, Ueno T, Yoshida N, Akutsu Y, et al
    Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study.
    Anticancer Res. 2019;39:4441-4448.
    PubMed     Abstract available


  164. OHSAWA M, Hamai Y, Ibuki Y, Emi M, et al
    Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report.
    Anticancer Res. 2019;39:4399-4403.
    PubMed     Abstract available


  165. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2019;39:4337-4342.
    PubMed     Abstract available


  166. JINGU K, Takahashi N, Murakami Y, Ishikawa K, et al
    Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?
    Anticancer Res. 2019;39:4279-4283.
    PubMed     Abstract available


  167. MATSUMOTO A, Yuda M, Tanaka Y, Tanishima Y, et al
    Efficacy of Percutaneous Endoscopic Gastrostomy for Patients With Esophageal Cancer During Preoperative Therapy.
    Anticancer Res. 2019;39:4243-4248.
    PubMed     Abstract available


  168. MATSUNAGA N, Wakasaki T, Yasumatsu R, Kotake Y, et al
    Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4073-4077.
    PubMed     Abstract available


  169. SDRALIS EK, Davakis S, Syllaios A, Lorenzi B, et al
    Prognostic Value of Subcarinal Lymph Nodes in Minimally Invasive Esophagectomy for Cancer.
    Anticancer Res. 2019;39:4291-4295.
    PubMed     Abstract available


  170. TOMASOVIC-LONCARIC C, Fucic A, Andabak A, Andabak M, et al
    Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk.
    Anticancer Res. 2019;39:4285-4289.
    PubMed     Abstract available


  171. CHRYSOVERGIS A, Papanikolaou V, Tsiambas E, Stavraka C, et al
    P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
    Anticancer Res. 2019;39:4137-4142.
    PubMed     Abstract available


  172. HUANG TS, Lee JJ, Li YS, Cheng SP, et al
    Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.
    Anticancer Res. 2019;39:4095-4100.
    PubMed     Abstract available


    July 2019
  173. TOAN NL, Hang NT, Luu NK, VAN Mao C, et al
    Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer.
    Anticancer Res. 2019;39:3727-3737.
    PubMed     Abstract available


  174. LANDGRAF V, Griessmann M, Roller J, Polednik C, et al
    DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines.
    Anticancer Res. 2019;39:3633-3639.
    PubMed     Abstract available


  175. SEO YS, Kim TH, Lim H, Oh JS, et al
    Phenformin Induces Caspase-dependent Apoptosis of FaDu Head and Neck Squamous Cell Carcinoma Cells.
    Anticancer Res. 2019;39:3499-3506.
    PubMed     Abstract available


  176. ITO T, Honma Y, Hirano H, Shoji H, et al
    S-1 Monotherapy After Failure of Platinum Plus 5-Fluorouracil Chemotherapy in Recurrent or Metastatic Esophageal Carcinoma.
    Anticancer Res. 2019;39:3931-3936.
    PubMed     Abstract available


  177. STAUB Y, Nishiyama A, Suga Y, Fujita M, et al
    Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.
    Anticancer Res. 2019;39:3871-3878.
    PubMed     Abstract available


  178. KIM JY, Park YJ, Lee BM, Yoon S, et al
    Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Anticancer Res. 2019;39:3757-3765.
    PubMed     Abstract available


  179. UCHIDA S, Kobayashi K, Ohno S, Sakagami H, et al
    Induction of Non-Apoptotic Cell Death by Adrenergic Agonists in Human Oral Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2019;39:3519-3529.
    PubMed     Abstract available


  180. IMANARI K, Hashimoto M, Wakabayashi H, Okudaira N, et al
    Quantitative Structure-Cytotoxicity Relationship of Azulene Amide Derivatives.
    Anticancer Res. 2019;39:3507-3518.
    PubMed     Abstract available


    June 2019
  181. KITAGAWA H, Iwabu J, Yokota K, Namikawa T, et al
    Intraoperative Neurological Monitoring During Neck Dissection for Esophageal Cancer With Aberrant Subclavian Artery.
    Anticancer Res. 2019;39:3203-3205.
    PubMed     Abstract available


  182. MIKOSHIBA T, Ozawa H, Saito S, Ikari Y, et al
    Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients.
    Anticancer Res. 2019;39:3059-3065.
    PubMed     Abstract available


  183. TOYOKAWA T, Tamura T, Sakurai K, Kubo N, et al
    Postoperative Inflammation Is an Independent Prognostic Factor in Patients With Thoracic Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2777-2784.
    PubMed     Abstract available


  184. LORENZI B, Davakis S, Syllaios A, Kordzadeh A, et al
    Minimally Invasive Circumferential Hiatal Dissection for the Treatment of Adenocarcinoma of the Distal Esophagus and Esophago-gastric Junction: Technical Considerations Combined With Histopathological Outcomes.
    Anticancer Res. 2019;39:3219-3225.
    PubMed     Abstract available


  185. ZHANG D, Liao X, Tang Y, Meyer RG, et al
    Warthin-like Mucoepidermoid Carcinoma of the Parotid Gland: Unusual Morphology and Diagnostic Pitfalls.
    Anticancer Res. 2019;39:3213-3217.
    PubMed     Abstract available


  186. GOTO M, Okitsu H, Yuasa Y, Kuramoto S, et al
    Thoracoscopic Oesophagectomy Using Prone Positioning for Oesophageal Cancer With Right Aortic Arch: A Case Report.
    Anticancer Res. 2019;39:3207-3211.
    PubMed     Abstract available


  187. SOHDA M, Miyazaki T, Sakai M, Kumakura Y, et al
    Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.
    Anticancer Res. 2019;39:3167-3175.
    PubMed     Abstract available


  188. TAKAHASHI H, Sakakura K, Arisaka Y, Tokue A, et al
    Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:3039-3046.
    PubMed     Abstract available


  189. HUANG SJ, Tseng YK, Lo YH, Wu PC, et al
    Association of SDF-1 and CXCR4 Polymorphisms With Susceptibility to Oral and Pharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2891-2902.
    PubMed     Abstract available


  190. KARAGIANNIS AK, Philippou A, Tseleni-Balafouta S, Zevolis E, et al
    IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
    Anticancer Res. 2019;39:2811-2819.
    PubMed     Abstract available


  191. LIU C, Jiang YH, Zhao ZL, Wu HW, et al
    Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2019;39:2729-2737.
    PubMed     Abstract available


  192. MIRONSKA A, Lukaszewicz-Zajac M, Mroczko B
    Clinical Significance of Selected Chemokines in Thyroid Cancer.
    Anticancer Res. 2019;39:2715-2720.
    PubMed     Abstract available


    May 2019
  193. TAMAGAWA A, Aoyama T, Tamagawa H, Ju M, et al
    Influence of Postoperative Pneumonia on Esophageal Cancer Survival and Recurrence.
    Anticancer Res. 2019;39:2671-2678.
    PubMed     Abstract available


  194. SAEJIA P, Lirdprapamongkol K, Svasti J, Paricharttanakul NM, et al
    Perfluorooctanoic Acid Enhances Invasion of Follicular Thyroid Carcinoma Cells Through NF-kappaB and Matrix Metalloproteinase-2 Activation.
    Anticancer Res. 2019;39:2429-2435.
    PubMed     Abstract available


  195. TANAKA Y, Yamada A, Hirata S, Tanaka H, et al
    Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study.
    Anticancer Res. 2019;39:2615-2625.
    PubMed     Abstract available


  196. JEHN P, Dittmann J, Zimmerer R, Stier R, et al
    Survival Rates According to Tumour Location in Patients With Surgically Treated Oral and Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2527-2533.
    PubMed     Abstract available


  197. MORIKAWA T, Kosugi A, Shibahara T
    The Utility of Optical Instrument "ORALOOK(R)" in the Early Detection of High-risk Oral Mucosal Lesions.
    Anticancer Res. 2019;39:2519-2525.
    PubMed     Abstract available


  198. GADDUCCI A, Giuliani D, Cosio S, Lissoni A, et al
    Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.
    Anticancer Res. 2019;39:2513-2517.
    PubMed     Abstract available


  199. ANTUNES DM, Rodrigues MFSD, Guimaraes DM, Duarte CME, et al
    Nonsteroidal Anti-inflammatory Drugs Modulate Gene Expression of Inflammatory Mediators in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2385-2394.
    PubMed     Abstract available


  200. NOWINSKA K, Ciesielska U, Piotrowska A, Jablonska K, et al
    MCM5 Expression Is Associated With the Grade of Malignancy and Ki-67 Antigen in LSCC.
    Anticancer Res. 2019;39:2325-2335.
    PubMed     Abstract available


    April 2019
  201. PAENG JY, Kim JW, Lee ST
    Changes in Hyoid Bone Position and Cross-sectional Area of Pharyngeal Airway After Oral Cancer Surgery.
    Anticancer Res. 2019;39:2097-2104.
    PubMed     Abstract available


  202. WOOKEY VB, Appiah AK, Kallam A, Ernani V, et al
    HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2019;39:1907-1914.
    PubMed     Abstract available


  203. HUANG CH, Hsieh TC, Chang BS, Wang TF, et al
    Enteral Access Potentially Endangers Esophageal Carcinoma Patients Under Multi-modality Therapy: A Population-based Study.
    Anticancer Res. 2019;39:2227-2232.
    PubMed     Abstract available


  204. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Abstract available


  205. DE PAZ D, Young CK, Chien HT, Tsao CK, et al
    Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:2025-2033.
    PubMed     Abstract available


  206. DE SANCTIS V, Belgioia L, Cante D, LA Porta MR, et al
    Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.
    Anticancer Res. 2019;39:1935-1942.
    PubMed     Abstract available


  207. FUJIMASA K, Ohike N, Norose T, Isobe T, et al
    Frequent and Specific Involvement of Changes of the p16-RB Pathway in Esophageal Neuroendocrine Carcinoma.
    Anticancer Res. 2019;39:1927-1934.
    PubMed     Abstract available


  208. MIYAMOTO K, Minegaki T, Tanahashi M, Yamamoto A, et al
    Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2019;39:1813-1820.
    PubMed     Abstract available


  209. AURELLO P, Berardi G, Moschetta G, Cinquepalmi M, et al
    Recurrence Following Anastomotic Leakage After Surgery for Carcinoma of the Distal Esophagus and Gastroesophageal Junction: A Systematic Review.
    Anticancer Res. 2019;39:1651-1660.
    PubMed     Abstract available


    March 2019
  210. HAMAI Y, Emi M, Ibuki Y, Murakami Y, et al
    Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1433-1440.
    PubMed     Abstract available


  211. NOZATO T, Koizumi T, Hayashi Y, Iida M, et al
    Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.
    Anticancer Res. 2019;39:1365-1373.
    PubMed     Abstract available


  212. NAKAMURA H, Tamaki S, Yagyuu T, Yamakawa N, et al
    Relationship Between EGFR Expression in Oral Cancer Cell Lines and Cetuximab Antibody-dependent Cell-mediated Cytotoxicity.
    Anticancer Res. 2019;39:1275-1282.
    PubMed     Abstract available


  213. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Abstract available


  214. MOTOYAMA S, Sato Y, Wakita A, Kawakita Y, et al
    Extensive Lymph Node Dissection Around the Left Laryngeal Nerve Achieved With Robot-assisted Thoracoscopic Esophagectomy.
    Anticancer Res. 2019;39:1337-1342.
    PubMed     Abstract available


  215. SUNDBERG J, Korytowska M, Burgos PM, Blomgren J, et al
    Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1293-1300.
    PubMed     Abstract available


  216. CHRYSOVERGIS A, Papanikolaou VS, Tsiambas E, Ragos V, et al
    Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1253-1257.
    PubMed     Abstract available


  217. MURAKI Y, Hasegawa T, Takeda D, Ueha T, et al
    Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1205-1216.
    PubMed     Abstract available


  218. KEMPER M, Strohm T, Grupp K, Ghadban T, et al
    Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.
    Anticancer Res. 2019;39:1191-1196.
    PubMed     Abstract available


    February 2019
  219. TAI TS, Lin PM, Wu CF, Hung SK, et al
    CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An In Vitro Study.
    Anticancer Res. 2019;39:713-720.
    PubMed     Abstract available


  220. SUZUKI H, Tamaki T, Nishio M, Terada H, et al
    Uptake of (18)F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage.
    Anticancer Res. 2019;39:1043-1049.
    PubMed     Abstract available


  221. ASAKA S, Shimakawa T, Yamaguchi K, Katsube T, et al
    Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome.
    Anticancer Res. 2019;39:979-985.
    PubMed     Abstract available


  222. LI MU, Gu S, Mao R, Ning Y, et al
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
    Anticancer Res. 2019;39:949-956.
    PubMed     Abstract available


  223. ELTWERI AM, Thomas AL, Chung WY, Morgan B, et al
    The Effect of Supplementary Omegaven(R) on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
    Anticancer Res. 2019;39:853-861.
    PubMed     Abstract available


  224. ISRAEL Y, Rachmiel A, Gourevich K, Nagler R, et al
    Survival Probabilities Related to Histology, Grade and Stage in Patients With Salivary Gland Tumors.
    Anticancer Res. 2019;39:641-647.
    PubMed     Abstract available


  225. HAGIO K, Furuya S, Nakamura J, Maruyama S, et al
    High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma.
    Anticancer Res. 2019;39:557-565.
    PubMed     Abstract available


    January 2019
  226. NISHIUMI S, Fujigaki S, Kobayashi T, Kojima T, et al
    Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:519-526.
    PubMed     Abstract available


  227. LI CC, Fang HY, Lin CY, Shen WC, et al
    Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
    Anticancer Res. 2019;39:511-517.
    PubMed     Abstract available


  228. NOMOTO D, Yoshida N, Akiyama T, Kiyozumi Y, et al
    Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2019;39:471-475.
    PubMed     Abstract available


  229. KITAGAWA H, Namikawa T, Iwabu J, Uemura S, et al
    Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2019;39:467-470.
    PubMed     Abstract available


  230. MATSUNAGA T, Miyata H, Sugimura K, Motoori M, et al
    Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.
    Anticancer Res. 2019;39:449-458.
    PubMed     Abstract available


  231. ZEMBSKA A, Jawiarczyk-Przybylowska A, Wojtczak B, Bolanowski M, et al
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Anticancer Res. 2019;39:33-40.
    PubMed     Abstract available


  232. FURUKAWA K, Kawasaki G, Naruse T, Umeda M, et al
    Prognostic Significance of Pretreatment Lymphocyte-to-Monocyte Ratio in Patients with Tongue Cancer.
    Anticancer Res. 2019;39:405-412.
    PubMed     Abstract available


  233. LUNDIN E, Bergqvist M, Ahlgren J, Reizenstein J, et al
    Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in Orebro.
    Anticancer Res. 2019;39:285-289.
    PubMed     Abstract available


  234. DE MOURA CFG, Soares GR, Ribeiro FAP, Silva MJD, et al
    Evaluation of the Chemopreventive Activity of Grape Skin Extract Using Medium-term Oral Carcinogenesis Assay Induced by 4-Nitroquinoline 1-Oxide.
    Anticancer Res. 2019;39:177-182.
    PubMed     Abstract available


    December 2018
  235. HUANG CH, Wang TF, Wu YF, Cheng YT, et al
    Efficacy of Enteral Access in Patients with Esophageal Squamous Cell Carcinoma Under Neoadjuvant Therapy.
    Anticancer Res. 2018;38:6939-6945.
    PubMed     Abstract available


  236. TSAI CW, Hsu HM, Wang YC, Chang WS, et al
    Contribution of MMP2 Promoter Genotypes to Oral Cancer Susceptibility, Recurrence and Metastasis in Taiwan.
    Anticancer Res. 2018;38:6821-6826.
    PubMed     Abstract available


  237. NAKASHIMA Y, Saeki H, Hu Q, Tsuda Y, et al
    Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6809-6814.
    PubMed     Abstract available


  238. HAMADA J, Konishi H, Shiozaki A, Fujiwara H, et al
    Management of Pleural Effusion After Mediastinoscopic Radical Esophagectomy.
    Anticancer Res. 2018;38:6919-6925.
    PubMed     Abstract available


  239. FUSHIMI A, Takeyama H, Manome Y
    Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines.
    Anticancer Res. 2018;38:6759-6762.
    PubMed     Abstract available


  240. MURATA T, Kutsuna T, Kurohara K, Shimizu K, et al
    Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2018;38:6715-6720.
    PubMed     Abstract available


  241. MASSIMINO M, Tirro E, Stella S, Frasca F, et al
    Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.
    Anticancer Res. 2018;38:6653-6662.
    PubMed     Abstract available


    November 2018
  242. KATSURAHARA K, Shiozaki A, Fujiwara H, Konishi H, et al
    Relationship Between Postoperative CRP and Prognosis in Thoracic Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6513-6518.
    PubMed     Abstract available


  243. ISOZAKI Y, Yasuda S, Akutsu Y, Shimada H, et al
    Salvage Carbon-ion Radiotherapy for Isolated Lymph Node Recurrence Following Curative Resection of Esophageal Cancer.
    Anticancer Res. 2018;38:6453-6458.
    PubMed     Abstract available


  244. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Anticancer Res. 2018;38:6339-6352.
    PubMed     Abstract available


  245. BABA J, Kioi M, Akimoto K, Nagashima Y, et al
    Atypical Protein Kinase C lambda/iota Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6291-6297.
    PubMed     Abstract available


  246. SUZUKI H, Takano G, Hanai N, Nishikawa D, et al
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck.
    Anticancer Res. 2018;38:6485-6490.
    PubMed     Abstract available


  247. ELLIOTT DA, Rana SR, Nabavizadeh N, Chen Y, et al
    Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns.
    Anticancer Res. 2018;38:6375-6379.
    PubMed     Abstract available


  248. ARIMOTO S, Hasegawa T, Takeda D, Saito I, et al
    Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:6157-6162.
    PubMed     Abstract available


  249. LEE MK, Park JH, Gi SH, Hwang YS, et al
    IL-1beta Induces Fascin Expression and Increases Cancer Invasion.
    Anticancer Res. 2018;38:6127-6132.
    PubMed     Abstract available


  250. OPITZ P, Herbarth O, Seidel A, Boehm A, et al
    Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
    Anticancer Res. 2018;38:6113-6119.
    PubMed     Abstract available


  251. TURBAT-HERRERA EA, Kilpatrick MJ, Chen J, Meram AT, et al
    Cystathione beta-Synthase Is Increased in Thyroid Malignancies.
    Anticancer Res. 2018;38:6085-6090.
    PubMed     Abstract available


    October 2018
  252. TSIAMBAS E, Riziotis C, Mastronikolis NS, Peschos D, et al
    Comparative p16(IKN4A) Expression in Laryngeal Carcinoma and Cervical Cancer Precursors: A Real-time Grid-based Immunocytochemistry Analysis.
    Anticancer Res. 2018;38:5805-5810.
    PubMed     Abstract available


  253. WOESTEMEIER A, Ghadban T, Riethdorf S, Harms-Effenberger K, et al
    Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
    Anticancer Res. 2018;38:5665-5669.
    PubMed     Abstract available


  254. PARK R, Williamson S, Kasi A, Saeed A, et al
    Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Anticancer Res. 2018;38:5569-5580.
    PubMed     Abstract available


  255. YIN F, Piao J, Liu X, Lai J, et al
    Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls.
    Anticancer Res. 2018;38:5999-6002.
    PubMed     Abstract available


  256. ATHAUDA A, Watkins D, Mohammed K, Chau I, et al
    Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.
    Anticancer Res. 2018;38:5943-5949.
    PubMed     Abstract available


  257. VARRA V, Woody NM, Reddy C, Joshi NP, et al
    Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
    Anticancer Res. 2018;38:5825-5830.
    PubMed     Abstract available


  258. KANG SM, Kim J, Kang SH, Oh SY, et al
    Up-regulation of Bone Morphogenetic Protein 7 by 2-Hydroxycinnamaldehyde Attenuates HNSCC Cell Invasion.
    Anticancer Res. 2018;38:5747-5757.
    PubMed     Abstract available


  259. KIM JY, Park Y, Lee BM, Kim HS, et al
    P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Anticancer Res. 2018;38:5685-5692.
    PubMed     Abstract available


  260. VIRGILIO E, Ceci D, Cavallini M
    Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:5581-5587.
    PubMed     Abstract available


    September 2018
  261. BETTE M, Nowak-Rossmann A, Mandic R
    The Auricular VX2 Carcinoma Is a Suitable Animal Model for Identifying Biomarkers for HNSCC Therapy Response.
    Anticancer Res. 2018;38:5067-5078.
    PubMed     Abstract available


  262. ARIGAMI T, Uchikado Y, Omoto I, Sasaki K, et al
    Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5447-5452.
    PubMed     Abstract available


  263. MERZ S, Timmesfeld N, Stuck BA, Wiegand S, et al
    Impact of Lymph Node Yield on Outcome of Patients with Head and Neck Cancer and pN0 Neck.
    Anticancer Res. 2018;38:5347-5350.
    PubMed     Abstract available


  264. HAYATA K, Ojima T, Nakamori M, Nakamura M, et al
    Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
    Anticancer Res. 2018;38:5267-5273.
    PubMed     Abstract available


  265. HEJLEH TA, Abushahin L, Keech J, Allen BG, et al
    Screening Patients with Esophageal Cancer to Determine Eligibility for Adjuvant Treatment Trials.
    Anticancer Res. 2018;38:5247-5251.
    PubMed     Abstract available


  266. JIANG P, Gu L, Zhou Y, Zhao Y, et al
    Synchronous Laryngeal Squamous Cell Carcinoma and Intrahepatic Cholangiocarcinoma Present in an Obese Male with Poor Prognosis.
    Anticancer Res. 2018;38:5547-5550.
    PubMed     Abstract available


  267. KUWAHARA T, Takahashi H, Sano D, Matsuoka M, et al
    Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5321-5330.
    PubMed     Abstract available


  268. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Abstract available


  269. FURUKAWA T, Hamai Y, Hihara J, Emi M, et al
    Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.
    Anticancer Res. 2018;38:5239-5245.
    PubMed     Abstract available


  270. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:5211-5216.
    PubMed     Abstract available


  271. KIM H, Yang JM, Ahn SH, Jeong WJ, et al
    Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5193-5200.
    PubMed     Abstract available


  272. KIM JY, Son JY, Lee BM, Kim HS, et al
    Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Anticancer Res. 2018;38:5149-5157.
    PubMed     Abstract available


    August 2018
  273. KONISHI T, Shiozaki A, Fujiwara H, Konishi H, et al
    Comparison of Feeding Jejunostomy via Gastric Tube Versus Jejunum After Esophageal Cancer Surgery.
    Anticancer Res. 2018;38:4941-4945.
    PubMed     Abstract available


  274. RADES D, Staackmann C, Janssen S
    Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer.
    Anticancer Res. 2018;38:4833-4837.
    PubMed     Abstract available


  275. BERSANI C, Haeggblom L, Ursu RG, Giusca SE, et al
    Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
    Anticancer Res. 2018;38:4683-4690.
    PubMed     Abstract available


  276. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4661-4666.
    PubMed     Abstract available


  277. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 3-(N-Cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:4459-4467.
    PubMed     Abstract available


  278. NAGAI J, Shi H, Kubota Y, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of Pyrano[4,3-b]chromones.
    Anticancer Res. 2018;38:4449-4457.
    PubMed     Abstract available


    July 2018
  279. STROJAN P, Zakotnik B, Zumer B, Karner K, et al
    Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer.
    Anticancer Res. 2018;38:4213-4220.
    PubMed     Abstract available


  280. STAACKMANN C, Janssen S, Schild SE, Rades D, et al
    A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.
    Anticancer Res. 2018;38:4199-4202.
    PubMed     Abstract available


  281. BAXA J, Ferda J, Ferdova E, Vojtisek R, et al
    Hybrid Imaging PET/CT with Application of (18)F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy.
    Anticancer Res. 2018;38:4153-4157.
    PubMed     Abstract available


  282. ALOTAIBY F, Song F, Boyce BJ, Cao D, et al
    Unusual Papillary Squamous Cell Carcinoma of the Tip of Tongue Presenting in a Patient Status Post Heart Transplant.
    Anticancer Res. 2018;38:4203-4206.
    PubMed     Abstract available


  283. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Associations Between MTHFR Polymorphisms and the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4021-4026.
    PubMed     Abstract available


  284. MOREIRA LF, Maino MM, Garbin HI, DA Natividade GR, et al
    CD117 Expression in Squamous Cell Carcinoma of the Oesophagus.
    Anticancer Res. 2018;38:3929-3933.
    PubMed     Abstract available


  285. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-(N-cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:3897-3906.
    PubMed     Abstract available


  286. MERAM AT, Chen J, Patel S, Kim DD, et al
    Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.
    Anticancer Res. 2018;38:3843-3852.
    PubMed     Abstract available


    June 2018
  287. SIANO M, Jarisch N, Joerger M, Espeli V, et al
    Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer.
    Anticancer Res. 2018;38:3725-3729.
    PubMed     Abstract available


  288. RADES D, Bartscht T, Idel C, Schild SE, et al
    Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with >/=42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.
    Anticancer Res. 2018;38:3653-3656.
    PubMed     Abstract available


  289. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Abstract available


  290. KIM JS, Choi DW, Kim CS, Yu SK, et al
    MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells.
    Anticancer Res. 2018;38:3477-3485.
    PubMed     Abstract available


  291. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Abstract available


  292. JULOORI A, Koyfman SA, Geiger JL, Joshi NP, et al
    Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
    Anticancer Res. 2018;38:3543-3549.
    PubMed     Abstract available


  293. UESAWA Y, Sakagami H, Shi H, Hirose M, et al
    Quantitative Structure-Cytotoxicity Relationship of Furo[2,3-b]chromones.
    Anticancer Res. 2018;38:3283-3290.
    PubMed     Abstract available


  294. BOLM L, Kasmann L, Paysen A, Karapetis C, et al
    Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:3231-3242.
    PubMed     Abstract available


  295. GANESH D, Sreenivasan P, Ohman J, Wallstrom M, et al
    Potentially Malignant Oral Disorders and Cancer Transformation.
    Anticancer Res. 2018;38:3223-3229.
    PubMed     Abstract available


    May 2018
  296. CHOI SH, Chang JS, Choi J, Park SH, et al
    Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Anticancer Res. 2018;38:3165-3173.
    PubMed     Abstract available


  297. RAMQVIST T, Ursu RG, Haeggblom L, Mirzaie L, et al
    Human Polyomaviruses Are Not Frequently Present in Cancer of the Salivary Glands.
    Anticancer Res. 2018;38:2871-2874.
    PubMed     Abstract available


  298. ASSAO A, Yoshino PM, Medeiros MCM, Carvalho AL, et al
    Moesin Involvement in Oral Carcinogenesis of the Lower Lip.
    Anticancer Res. 2018;38:2755-2760.
    PubMed     Abstract available


  299. KRAMER B, Kneissle M, Birk R, Rotter N, et al
    Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.
    Anticancer Res. 2018;38:2723-2731.
    PubMed     Abstract available


    April 2018
  300. FARINA E, Capuccini J, Macchia G, Caravatta L, et al
    Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.
    Anticancer Res. 2018;38:2409-2414.
    PubMed     Abstract available


  301. SHIMAKAWA T, Naritaka Y, Asaka S, Miyazawa M, et al
    Innovations for Cervical Esophagogastrostomy in Thoracic Esophageal Cancer Operations.
    Anticancer Res. 2018;38:2323-2327.
    PubMed     Abstract available


  302. SHIH LC, Li CH, Sun KT, Chen LY, et al
    Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
    Anticancer Res. 2018;38:2087-2092.
    PubMed     Abstract available


  303. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Abstract available


  304. MASTRONIKOLIS NS, Tsiambas E, Fotiades PP, Baliou E, et al
    Numerical Imbalances of Chromosome 7 in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:2339-2342.
    PubMed     Abstract available


  305. FRIEDRICH RE, Reul A
    Periapical Cemento-osseous Dysplasia Is Rarely Diagnosed on Orthopantomograms of Patients with Neurofibromatosis Type 1 and Is Not a Gender-specific Feature of the Disease.
    Anticancer Res. 2018;38:2277-2284.
    PubMed     Abstract available


  306. SEDER CW, Mahon B, Hennon M, Thomas M, et al
    Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma.
    Anticancer Res. 2018;38:2195-2200.
    PubMed     Abstract available


    March 2018
  307. BERNARDI D, Asti E, Aiolfi A, Bonitta G, et al
    Outcome of Trimodal Therapy in Elderly Patients with Esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index.
    Anticancer Res. 2018;38:1815-1820.
    PubMed     Abstract available


  308. KUNIZAKI M, Hamasaki K, Wakata K, Tobinaga S, et al
    Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1807-1813.
    PubMed     Abstract available


  309. SUROV A, Leifels L, Meyer HJ, Winter K, et al
    Associations Between Histogram Analysis DCE MRI Parameters and Complex (18)F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1637-1642.
    PubMed     Abstract available


  310. RADES D, Seidl D, Janssen S, Hakim SG, et al
    A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers.
    Anticancer Res. 2018;38:1611-1613.
    PubMed     Abstract available


  311. GUO JC, Lin CC, Huang TC, Huang PM, et al
    Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:1569-1577.
    PubMed     Abstract available


  312. LEE CC, Lin ML, Meng M, Chen SS, et al
    Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
    Anticancer Res. 2018;38:1377-1389.
    PubMed     Abstract available


  313. GLAAS MF, Wiek C, Wolter LM, Roellecke K, et al
    Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2018;38:1317-1325.
    PubMed     Abstract available


  314. ZIVICOVA V, Gal P, Mifkova A, Novak S, et al
    Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1279-1290.
    PubMed     Abstract available


  315. SUEFUJI H, Koto M, Demizu Y, Saitoh JI, et al
    A Retrospective Multicenter Study of Carbon Ion Radiotherapy for Locally Advanced Olfactory Neuroblastomas.
    Anticancer Res. 2018;38:1665-1670.
    PubMed     Abstract available


  316. POST CM, Lin C, Adeberg S, Gupta M, et al
    National Practice Patterns for Clinical T1N0 Nasopharyngeal Cancer in the Elderly: A National Cancer Data Base Analysis.
    Anticancer Res. 2018;38:1651-1657.
    PubMed     Abstract available


  317. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Abstract available


  318. KAWASAKI G, Naruse T, Furukawa K, Umeda M, et al
    mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study.
    Anticancer Res. 2018;38:1623-1628.
    PubMed     Abstract available


  319. YUDA M, Nishikawa K, Takahashi K, Kurogochi T, et al
    A Strategy for Using Intraoperative Nerve Monitoring During Esophagectomy to Prevent Recurrent Laryngeal Nerve Palsy.
    Anticancer Res. 2018;38:1563-1567.
    PubMed     Abstract available


  320. SU W, Miles BA, Posner M, Som P, et al
    Surveillance Imaging in HPV-related Oropharyngeal Cancer.
    Anticancer Res. 2018;38:1525-1529.
    PubMed     Abstract available


  321. KATO K, Shimasaki M, Kato T, Segami N, et al
    Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1361-1368.
    PubMed     Abstract available


  322. SAIDAK Z, Morisse MC, Chatelain D, Sauzay C, et al
    Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours.
    Anticancer Res. 2018;38:1343-1352.
    PubMed     Abstract available


  323. HATA M
    Radiation Therapy for Angiosarcoma of the Scalp: Total Scalp Irradiation and Local Irradiation.
    Anticancer Res. 2018;38:1247-1253.
    PubMed     Abstract available


    February 2018
  324. KONISHI H, Fujiwara H, Shiozaki A, Shoda K, et al
    Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1017-1023.
    PubMed     Abstract available


  325. SAKAI M, Sohda M, Miyazaki T, Yoshida T, et al
    Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy.
    Anticancer Res. 2018;38:933-938.
    PubMed     Abstract available


  326. NAKAJIMA M, Muroi H, Kikuchi M, Takahashi M, et al
    Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
    Anticancer Res. 2018;38:911-918.
    PubMed     Abstract available


  327. YANAGI M, Sasaki K, Uchikado Y, Omoto I, et al
    Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer.
    Anticancer Res. 2018;38:893-900.
    PubMed     Abstract available


  328. ERNST BP, Mikstas C, Stover T, Stauber R, et al
    Association of eIF4E and SPARC Expression with Lymphangiogenesis and Lymph Node Metastasis in Hypopharyngeal Cancer.
    Anticancer Res. 2018;38:699-706.
    PubMed     Abstract available


  329. TATEBE H, Doi H, Ishikawa K, Kawakami H, et al
    Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Anticancer Res. 2018;38:979-986.
    PubMed     Abstract available


  330. YOSHIDA S, Shimo T, Murase Y, Takabatake K, et al
    The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:955-962.
    PubMed     Abstract available


  331. SAKAGAMI H, Okudaira N, Uesawa Y, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Azolylchromones.
    Anticancer Res. 2018;38:763-770.
    PubMed     Abstract available


  332. UESAWA Y, Sakagami H, Okudaira N, Toda K, et al
    Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
    Anticancer Res. 2018;38:817-823.
    PubMed     Abstract available


  333. CIERPIKOWSKI P, Lis-Nawara A, Gajdzis P, Bar J, et al
    PDGFRalpha/HER2 and PDGFRalpha/p53 Co-expression in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:795-802.
    PubMed     Abstract available


    January 2018
  334. EGUCHI K, Suzuki M, Ida S, Mori K, et al
    Association Between Laryngopharyngeal Reflux and Radiation-induced Mucositis in Head and Neck Cancer.
    Anticancer Res. 2018;38:477-480.
    PubMed     Abstract available


  335. RADES D, Bartscht T, Idel C, Hakim SG, et al
    Re-irradiation with 36 Gy (1.5 Gy Twice Daily) Plus Paclitaxel for Advanced Recurrent and Previously Irradiated SCCHN is Feasible.
    Anticancer Res. 2018;38:519-523.
    PubMed     Abstract available


  336. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Abstract available


  337. DOMINGUEZ C, Rosa M, George TB, Pimiento J, et al
    Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
    Anticancer Res. 2018;38:367-372.
    PubMed     Abstract available


  338. ISHIBASHI K, Ishii K, Sugiyama G, Sumida T, et al
    Deregulation of Nicotinamide N-Methyltransferase and Gap Junction Protein Alpha-1 Causes Metastasis in Adenoid Cystic Carcinoma.
    Anticancer Res. 2018;38:187-197.
    PubMed     Abstract available


    December 2017
  339. ANDREOU A, Pesthy S, Struecker B, Dadras M, et al
    Incidence and Risk Factors of Symptomatic Hiatal Hernia Following Resection for Gastric and Esophageal Cancer.
    Anticancer Res. 2017;37:7031-7036.
    PubMed     Abstract available


  340. SENTO S, Kitamura N, Yamamoto T, Nakashiro K, et al
    Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients.
    Anticancer Res. 2017;37:6977-6981.
    PubMed     Abstract available


  341. FARINA E, Ferioli M, Castellucci P, Farina A, et al
    (18)F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art.
    Anticancer Res. 2017;37:6523-6532.
    PubMed     Abstract available


  342. RADES D, Bajrovic A, Bartscht T
    Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands.
    Anticancer Res. 2017;37:7011-7015.
    PubMed     Abstract available


  343. KOTSUMA T, Yamazaki H, Masui K, Yoshida K, et al
    Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Anticancer Res. 2017;37:6887-6892.
    PubMed     Abstract available


  344. FUJII H, Iihara H, Kajikawa N, Kobayashi R, et al
    Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.
    Anticancer Res. 2017;37:6831-6837.
    PubMed     Abstract available


  345. KURODA H, Kurio N, Shimo T, Matsumoto K, et al
    Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.
    Anticancer Res. 2017;37:6731-6737.
    PubMed     Abstract available


    November 2017
  346. CHO JH, Joo YH, Shin EY, Park EJ, et al
    Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:6269-6280.
    PubMed     Abstract available


  347. LIU KC, Lin YJ, Hsiao YT, Lin ML, et al
    Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.
    Anticancer Res. 2017;37:6107-6118.
    PubMed     Abstract available


  348. CHOU PY, Lee MM, Lin SY, Sheu MJ, et al
    Pipoxolan Exhibits Antitumor Activity Toward Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-mediated Apoptosis.
    Anticancer Res. 2017;37:6391-6400.
    PubMed     Abstract available


  349. UESAWA Y, Sakagami H, Ikezoe N, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of Aurones.
    Anticancer Res. 2017;37:6169-6176.
    PubMed     Abstract available


  350. SAKAGAMI H, Uesawa Y, Masuda Y, Tomomura M, et al
    Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
    Anticancer Res. 2017;37:6161-6168.
    PubMed     Abstract available


  351. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:6119-6123.
    PubMed     Abstract available


  352. SUGITA Y, Takao K, Uesawa Y, Sakagami H, et al
    Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity.
    Anticancer Res. 2017;37:5919-5924.
    PubMed     Abstract available


    October 2017
  353. MOTOYAMA S, Sato Y, Sasaki T, Wakita A, et al
    Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Anticancer Res. 2017;37:5837-5843.
    PubMed     Abstract available


  354. HAMAI Y, Hihara J, Emi M, Furukawa T, et al
    Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5639-5646.
    PubMed     Abstract available


  355. GOPPEL J, Mockelmann N, Munscher A, Sauter G, et al
    Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:5435-5440.
    PubMed     Abstract available


  356. LIM HS, Kim CS, Kim JS, Yu SK, et al
    Suppression of Oral Carcinoma Oncogenic Activity by microRNA-203 via Down-regulation of SEMA6A.
    Anticancer Res. 2017;37:5425-5433.
    PubMed     Abstract available


  357. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Abstract available


  358. JANG JY, Pak KJ, Yi KI, Ki YK, et al
    Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
    Anticancer Res. 2017;37:5899-5905.
    PubMed     Abstract available


  359. FUJIMOTO Y, Nakashima Y, Sasaki S, Jogo T, et al
    Chemoradiotherapy for Solitary Skeletal Muscle Metastasis from Oesophageal Cancer: Case Report and Brief Literature Review.
    Anticancer Res. 2017;37:5687-5691.
    PubMed     Abstract available


  360. MASTRONIKOLIS NS, Tsiambas E, Papadas TA, Karameris A, et al
    Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.
    Anticancer Res. 2017;37:5521-5524.
    PubMed     Abstract available


  361. PISANI LP, Estadella D, Ribeiro DA
    The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
    Anticancer Res. 2017;37:5389-5394.
    PubMed     Abstract available


  362. ANGELIERI F, Yujra VQ, Oshima CTF, Ribeiro DA, et al
    Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review.
    Anticancer Res. 2017;37:5383-5388.
    PubMed     Abstract available


  363. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Abstract available


    September 2017
  364. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer.
    Anticancer Res. 2017;37:5301-5307.
    PubMed     Abstract available


  365. SOHDA M, Kumakura Y, Saito H, Kuriyama K, et al
    Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival.
    Anticancer Res. 2017;37:5045-5051.
    PubMed     Abstract available


  366. KUMABE A, Zenda S, Motegi A, Onozawa M, et al
    Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5039-5044.
    PubMed     Abstract available


  367. FRANZEN AM, Coordes A, Franzen CK, Guenzel T, et al
    Are Multiple Tumors of the Parotid Gland Uncommon or Underestimated?
    Anticancer Res. 2017;37:5263-5267.
    PubMed     Abstract available


  368. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Abstract available


  369. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Abstract available


  370. GUTSCHENRITTER T, Machiorlatti M, Vesely S, Ahmad B, et al
    Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.
    Anticancer Res. 2017;37:5019-5025.
    PubMed     Abstract available


  371. OKAMOTO JY, Miyazaki A, Kobayashi JI, Miyamoto S, et al
    Induction and Analysis of Cytotoxic T-Lymphocytes that Recognize Autologous Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4889-4897.
    PubMed     Abstract available


    August 2017
  372. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Abstract available


  373. LV Y, Jia C, Jiang A, Zhang H, et al
    Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer.
    Anticancer Res. 2017;37:4399-4403.
    PubMed     Abstract available


  374. MOTOYAMA S, Sato Y, Maruyama K, Usami S, et al
    Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer.
    Anticancer Res. 2017;37:4189-4194.
    PubMed     Abstract available


  375. HONJO H, Toh Y, Sohda M, Suzuki S, et al
    Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4147-4155.
    PubMed     Abstract available


  376. PARK Y, Son JY, Lee BM, Kim HS, et al
    Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Anticancer Res. 2017;37:4139-4146.
    PubMed     Abstract available


  377. KLATKA J, Grywalska E, Hymos A, Guz M, et al
    Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer.
    Anticancer Res. 2017;37:4059-4066.
    PubMed     Abstract available


  378. WANG Y, Xu G, Wang J, Li XH, et al
    Relationship of Th17/Treg Cells and Radiation Pneumonia in Locally Advanced Esophageal Carcinoma.
    Anticancer Res. 2017;37:4643-4647.
    PubMed     Abstract available


  379. ZHANG W, Yin G, Dai J, Sun YU, et al
    Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-kappaB Signaling Pathway in DMBA-treated Hamsters.
    Anticancer Res. 2017;37:4041-4049.
    PubMed     Abstract available


  380. REITER M, Harreus U
    Total Glossectomy Without Laryngectomy for Advanced Squamous Cell Cancer of the Tongue: Functional and Oncological Results.
    Anticancer Res. 2017;37:4233-4237.
    PubMed     Abstract available


    July 2017
  381. KITAGAWA H, Namikawa T, Hanazaki K
    Neck Dissection and Thoracoscopic Esophagectomy in Esophageal Cancer with Aberrant Subclavian Artery.
    Anticancer Res. 2017;37:3787-3790.
    PubMed     Abstract available


  382. HONMA Y, Hokamura N, Nagashima K, Sudo K, et al
    Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Anticancer Res. 2017;37:3741-3749.
    PubMed     Abstract available


  383. USLU U, Schuler G, Breuninger H
    Factors Influencing Disease Progression in Patients with Head and Neck Melanoma.
    Anticancer Res. 2017;37:3811-3816.
    PubMed     Abstract available


  384. FENG X, Matsuo K, Zhang T, Hu Y, et al
    MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2017;37:3473-3481.
    PubMed     Abstract available


    June 2017
  385. KAWAI T, Kochi M, Fujii M, Song K, et al
    Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:3301-3306.
    PubMed     Abstract available


  386. KALFERT D, Ludvikova M, Topolcan O, Celakovsky P, et al
    Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:3281-3286.
    PubMed     Abstract available


  387. UCHIYAMA Y, Kreiborg S, Murakami S, Tsujimoto T, et al
    Changes in the Submandibular Gland in Patients with Head and Neck Cancer After Radiation Therapy: A Preliminary Study.
    Anticancer Res. 2017;37:3239-3242.
    PubMed     Abstract available


  388. TARVAINEN L, Suojanen J, Kyyronen P, Lindqvist C, et al
    Occupational Risk for Oral Cancer in Nordic Countries.
    Anticancer Res. 2017;37:3221-3228.
    PubMed     Abstract available


  389. SUZUKI G, Yamazaki H, Aibe N, Masui K, et al
    Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: Factors Affecting Swallowing and Survival.
    Anticancer Res. 2017;37:3085-3092.
    PubMed     Abstract available


  390. MIYATA H, Sugimura K, Motoori M, Fujiwara Y, et al
    Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2017;37:3053-3059.
    PubMed     Abstract available


  391. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Abstract available


  392. JANG S, Patel PN, Kimple RJ, McCulloch TM, et al
    Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
    Anticancer Res. 2017;37:3045-3052.
    PubMed     Abstract available


  393. KRAMER B, Hock C, Schultz JD, Lammert A, et al
    Impact of Small Molecules on beta-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:2845-2852.
    PubMed     Abstract available


    May 2017
  394. RADES D, Maderer A, Panzner A, Hunold P, et al
    Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
    Anticancer Res. 2017;37:2703-2708.
    PubMed     Abstract available


  395. ZIVICOVA V, Broz P, Fik Z, Mifkova A, et al
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin.
    Anticancer Res. 2017;37:2275-2288.
    PubMed     Abstract available


  396. HAGEMANN J, Jacobi C, Hahn M, Schmid V, et al
    Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Anticancer Res. 2017;37:2201-2210.
    PubMed     Abstract available


  397. CIESIELSKA U, Zatonski T, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Anticancer Res. 2017;37:2407-2415.
    PubMed     Abstract available


    April 2017
  398. VEGH D, Banyai D, Hermann P, Nemeth Z, et al
    Type-2 Diabetes Mellitus and Oral Tumors in Hungary: A Long-term Comparative Epidemiological Study.
    Anticancer Res. 2017;37:1853-1857.
    PubMed     Abstract available


  399. DAVE E, Su W, Gupta V, Miles B, et al
    Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Anticancer Res. 2017;37:1847-1851.
    PubMed     Abstract available


  400. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Abstract available


  401. P NS, Kang DY, Kim BJ, Joung YH, et al
    Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells.
    Anticancer Res. 2017;37:1637-1646.
    PubMed     Abstract available


  402. SHIMIZU H, Shiozaki A, Fujiwara H, Konishi H, et al
    Short- and Long-term Progress of Recurrent Laryngeal Nerve Paralysis After Subtotal Esophagectomy.
    Anticancer Res. 2017;37:2019-2023.
    PubMed     Abstract available


  403. YUNOKI T, Tabuchi Y, Hayashi A
    Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Anticancer Res. 2017;37:1931-1934.
    PubMed     Abstract available


  404. FANG CY, Liew PL, Chen CL, Lin YH, et al
    High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1891-1899.
    PubMed     Abstract available


  405. FUJIMURA T, Takahashi K, Kambayashi Y, Furudate S, et al
    Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
    Anticancer Res. 2017;37:1885-1889.
    PubMed     Abstract available


    March 2017
  406. WAKITA A, Motoyama S, Nanjo H, Sato Y, et al
    PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:1433-1441.
    PubMed     Abstract available


  407. TORII C, Hida Y, Shindoh M, Akiyama K, et al
    Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1219-1225.
    PubMed     Abstract available


  408. NAKASHIMA S, Shiozaki A, Ichikawa D, Hikami S, et al
    Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1161-1167.
    PubMed     Abstract available


  409. TSENG HH, Tseng YK, You JJ, Kang BH, et al
    Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Anticancer Res. 2017;37:1059-1066.
    PubMed     Abstract available


  410. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Abstract available


  411. KOGASHIWA Y, Yasuda M, Sakurai H, Nakahira M, et al
    PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1417-1424.
    PubMed     Abstract available


  412. THEOCHARIS S, Kotta-Loizou I, Giaginis C, Alexandrou P, et al
    Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1313-1319.
    PubMed     Abstract available


  413. SAKAGAMI H, Masuda Y, Tomomura M, Yokose S, et al
    Quantitative Structure-Cytotoxicity Relationship of Chalcones.
    Anticancer Res. 2017;37:1091-1098.
    PubMed     Abstract available


  414. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Abstract available


  415. HARA K, Miyazaki T, Yokobori T, Yoshida T, et al
    Significance and Function of MicroRNA-7 in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1043-1048.
    PubMed     Abstract available


  416. SAKAGAMI H, Okudaira N, Masuda Y, Amano O, et al
    Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
    Anticancer Res. 2017;37:1023-1029.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: